Atsena Therapeutics, Inc.
Biotechnology company · Durham, North Carolina, United States
Atsena Therapeutics, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2019. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $870,675 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $90 million sold in a notice filed in 2025.
Atsena Therapeutics at a glance
What does Atsena Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $870,675 in total (2025). NIH funding came from the National Eye Institute.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $90 million sold (2025).
Frequently asked questions about Atsena Therapeutics
Where is Atsena Therapeutics headquartered?
Atsena Therapeutics, Inc. is headquartered in Durham, North Carolina, United States.
What does Atsena Therapeutics do?
Atsena Therapeutics, Inc. is a biotechnology company.
When was Atsena Therapeutics founded?
The earliest incorporation on record for Atsena Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Humacyte, Inc.Durham, North Carolina, United States
- Precision Biosciences IncDurham, North Carolina, United States
- Xilis, Inc.Durham, North Carolina, United States
- Deep Blue Medical Advances, Inc.Durham, North Carolina, United States
- inSoma Bio, Inc.Durham, North Carolina, United States
- Scion Neurostim, Inc.Durham, North Carolina, United States
- Sapere Bio, Inc.Durham, North Carolina, United States
- BioAesthetics CorpDurham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.